Lea Wagmann

[Lea Wagmann @lea_wagmann]

It is my honor to serve as Co-Guest Editor for the @BritJClinPharm

Feel free to contribute to our Special issue entitled „Clinical Toxicology of Psychoactive Drugs“.

Here is the Call for Papers (submission deadline June 1, 2025):
https://t.co/OmDv3op5oh

[Jana Stojanova @jsto7380]

#ICYMI Ep 9 of the Eight Drugs a Week podcast is out!

Florian & I speak to our #YSC @lea_wagmann, #HuaLin & #Sumith about the future of our professions

This one is titled 'When I'm 64!'🌱🎵

#clinicalpharmacology #clinicaltoxicology #ECR

https://t.co/8zA8mBHRLL

[Anal Bioanal Chem @AnalBioanalChem]

Towards clinical adherence #monitoring of oral endocrine #breastcancer therapies by LC-HRMS
by Markus R. Meyer @lea_wagmann @juliaradosa et al @Saar_Uni

#openaccess
https://t.co/7dYPahMp77

[Journal of Analytical Toxicology @JAnalyticalTox]

Want to know more about the analytical toxicology of the semi-synthetic cannabinoid hexahydrocannabinol (HHC)❓Manier et al. studied HHC in rat🐭and human samples, pooled human liver S9 fraction and analyzed drug products using HPLC–HRMS-MS. Read it all➡️https://t.co/PfVB2LZrBB

[Lea Wagmann @lea_wagmann]

@christophestove @NPS_issed Congrats!! 👍

[IATDMCT @IATDMCT]

Congratulations to, Juel and Soufian, winners of the best Young Scientist poster and oral awards 👏👏👏

🏆

#IATDMCT2023

[IATDMCT @IATDMCT]

We are really looking forward to see all of you in Oslo. Welcome to IATDMCT 2023! #iatdmct2023

Photo: @VisitOSLO Stenersen/Mohri

[Lea Wagmann @lea_wagmann]

@ToxBrigitte Congrats! Enjoy the new project ☺️ Regards from Rome

[Mathias Hohl @hohl_mathias]

👉Out now 🤩🙏! Thanks to all coauthors for a very fruitful cooperation. @FelixMahfoud @LucasLauder @lea_wagmann
Efficacy of Antihypertensive Drugs of Different Classes After Renal Denervation in Spontaneously Hypertensive Rats https://t.co/ZfRqccpNRj

[Journal of Analytical Toxicology @JAnalyticalTox]

Richter, @lea_wagmann, Brandt & Meyer look into the metabolic fate of the synthetic cannabinoid receptor agonists 2F-QMPSB and SGT-233 via in vitro testing. Isozyme mapping and carboxylesterases activity testing is also included! Read it all ➡️ https://t.co/wwcjXdhPk9

[Journal of Analytical Toxicology @JAnalyticalTox]

Suicide due to a combination of chloroquine and benzodiazepines 💊 is known as the so-called “Kusch method” in German-speaking countries. Jacobs, @lea_wagmann, Frankenfeld & Meyer report on a clinical toxicological follow-up analysis 🧪 in such a case. ➡️ https://t.co/Mtj6Wb4r5P

[Cayman Chemical @Cayman_Forensic]

A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay –
https://t.co/G0yn1ZVL8S

Significant cytotoxic potential observed for two cathinone derivatives and one synthetic cannabinoid.

[Christophe Stove @christophestove]

Review in @TherapeuticDrug #TherapeuticDrugMonitoring by @lea_wagmann on what biological matrix to use for the screening of new psychoactive substances in a clinical toxicology (emergency toxicology) context. 👇
https://t.co/ZSf55CNtvh

[Lea Wagmann @lea_wagmann]

Out now: Reviewing toxicokinetics with a focus on metabolism of new psychoactive substances in the zebrafish (larvae) model 🐟 https://t.co/Z5spDbLgif

[Lea Wagmann @lea_wagmann]

@dpasin117 Welcome @dpasin117

[Elena Lendoiro @Lendoiro_E]

Congratulations to the organizers of the #TIAFTVirtual meeting!! And to all the awardees #YSC #BestPaper #BestPoster #BestOral
See you in #Versailles2022 #TIAFT

[Enrico Gerace @GeraceForTox]

⏰Early wake up yesterday morning for me and my European colleagues for the first session of #TIAFTVirtual! A good talk on poisonings and NPS diffusion together with Lea and Dimitri!